What Researchers Did
Researchers conducted a literature review to evaluate the use of oxygen therapy for central retinal artery occlusion (CRAO) and propose a treatment algorithm.
What They Found
They found that central retinal artery occlusion (CRAO) typically leads to severe vision loss, but supplemental oxygen can help maintain retinal function. While experimental models suggest an ischemic window of just over 90 minutes, clinical vision return has been observed up to 24 hours after onset. A treatment algorithm recommends immediate supplemental oxygen at the highest possible fraction of inspired oxygen (FiO2) within 24 hours, followed by emergent hyperbaric oxygen (HBO2) if vision is not quickly restored.
What This Means for Canadian Patients
Canadian patients experiencing sudden, severe vision loss due to central retinal artery occlusion (CRAO) should seek immediate medical attention. Early administration of high-fraction inspired oxygen and potentially hyperbaric oxygen therapy could help preserve or restore vision.
Canadian Relevance
This study has no direct Canadian connection as it is a literature review without specific Canadian data or authors.
Study Limitations
As a literature review, this study synthesizes existing evidence and does not present new primary data or randomized controlled trials on oxygen therapy for CRAO.